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Abstract
Background: Suicide remains the 10th-ranked most frequent cause of death in the United States, accounting for
over 40,000 deaths per year. Nonfatal suicide attempts lead to over 200,000 hospitalizations and 600,000 emergency
department visits annually. Recent evidence indicates that responses to the commonly used Patient Health
Questionnaire (PHQ9) can identify outpatients who are at risk of suicide attempt and suicide death and that
specific psychotherapy or Care Management programs can prevent suicide attempts in high-risk patients.
Motivated by these developments, the NIMH-funded Mental Health Research Network has undertaken a
multisite trial of two outreach programs to prevent suicide attempts among outpatients identified by routinely
administered PHQ9 questionnaires.
Methods/design: Outpatients who are at risk of suicide attempt are automatically identified using data from
electronic health records (EHRs). Following a modified Zelen design, all those identified are assigned to continued
usual care (i.e., no contact) or to be offered one of two population-based outreach programs. A Care Management
intervention includes systematic outreach to assess suicide risk, EHR-based tools to implement risk-based care
pathways, and care management to facilitate recommended follow-up. A Skills Training intervention includes
interactive online training in Dialectical Behavior Therapy skills, supported by reminder and reinforcement messages
from a skills coach. Each intervention supplements, rather than replaces, usual care; participants may receive any other
services normally available. Interventions are delivered primarily by secure messaging through EHR patient portals.
Suicide attempts and deaths following randomization are identified using state vital statistics data and health system
EHR and insurance claim data. Primary evaluation will compare risk of suicide attempt or death over 18 months
according to the initial assignment, regardless of intervention participation. Recruitment is underway in three health
systems (Group Health Cooperative, HealthPartners, and Kaiser Permanente Colorado). Over 2500 participants have
been randomized as of 1 March 2016, with enrollment averaging approximately 100 per week.
Discussion: Assessing the effectiveness of population-based suicide prevention requires adherence to the principles
of pragmatic trials: population-based enrollment, accepting variable treatment participation, assessing outcomes using
health record data, and analyses based on intent-to-treat.
Trial registration: ClinicalTrials.gov registration #NCT02326883, registered on 23 December 2014.
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Background
Suicide remains the 10th-ranked most frequent cause of
death in the United States, accounting for over 40,000
deaths per year [1]. Nonfatal suicide attempts lead to
over 200,000 hospitalizations and 600,000 emergency
department visits each year [2, 3]. In contrast with other
common causes of death, suicide mortality has not
decreased over the last 25 years.
While prevention of suicide attempts and suicide
death is a public health priority, existing evidence does
not clearly support selective or secondary prevention
programs. In 2013, the US Preventive Services Task
Force found insufficient evidence to support the benefits
of screening for suicide risk in general medical outpa-
tients [4]. That review found insufficient evidence both
for the accuracy of screening tests and for the effective-
ness of interventions in those identified by screening.
More recent evidence indicates that responses to the
commonly used Patient Health Questionnaire (PHQ9)
can identify outpatients who are at increased risk of
suicide attempt and suicide death [5, 6]. Patients
reporting frequent thoughts of death or self-injury (the
ninth item of the PHQ9) show a sustained increase in
risk, with cumulative hazard approaching 4 % over
12 months. Reflecting this new evidence, the Joint
Commission recently issued a Sentinel Event Alert [7]
regarding detection of suicidal ideation in health care
settings.
In addition, growing evidence supports the effectiveness
of tertiary or indicated prevention interventions for high-
risk patients. Structured psychotherapy emphasizing spe-
cific behavioral and cognitive skills has been proven to
reduce risk among people who have made recent suicide
attempts [8–10]. Outreach and Care Management pro-
grams appear to reduce risk among people who have
made recent suicide attempts or high-risk patients treated
in mental health specialty clinics [11]. This evidence for
tertiary prevention suggests that similar interventions
could reduce risk in the broader (secondary prevention)
population of patients who are experiencing frequent
suicidal ideation.
Motivated by these developments, the National In-
stitute of Mental Health-funded Mental Health Re-
search Network has undertaken a multisite trial of two
population-based programs to prevent suicide at-
tempts among outpatients identified by routinely ad-
ministered depression questionnaires. Both programs
include systematic outreach and regular supportive
contact. One focuses on risk assessment and care
management [11], while the other includes online
training in specific skills from Dialectical Behavior
Therapy (DBT) [12]. This pragmatic trial will examine
whether either program can reduce long-term risk
compared to care as usual.
Methods
Overview
At participating health systems, outpatients who are at
increased risk of suicide attempt are identified using
data from electronic health records (EHRs). Following a
modified Zelen [13–15] design, all those identified are
automatically assigned to continue in usual care (i.e.,
no contact) or to be offered one of two population-
based prevention programs:
 A Care Management intervention including:
systematic outreach to assess risk of suicidal
behavior, EHR-based tools to implement risk-based
care pathways, and care management to facilitate
and monitor recommended follow-up care
 A Skills Training intervention including:
interactive online training in DBT skills [12],
supported by reminder and reinforcement
messages from a skills coach
Each intervention is intended to supplement, rather
than replace, usual care provided by specialty mental
health or primary care providers. Participants in all
three treatment groups are free to receive any other
services that are normally available, including pharma-
cotherapy, individual or group psychotherapy, or in-
patient care. Intervention services are delivered primarily
by online secure messaging through EHR patient portals
[16, 17]. Nonfatal and fatal suicide attempts following
randomization are identified using state vital statistics data
and diagnoses of self-inflicted injury from health system
clinical and insurance claim records [18, 19]. Primary
evaluation will compare risk of first suicide attempt (non-
fatal or fatal) over the 18 months following randomization.
Groups will be compared according to initial treatment
assignment, regardless of level of participation in either
intervention program.
Study settings
The study sites include three members of the Mental
Health Research Network: Group Health Cooperative,
HealthPartners, and Kaiser Permanente of Colorado.
These health systems provide general medical and men-
tal health specialty care as well as insurance coverage to
defined member/patient populations. Patients served are
representative of each health system’s geographic service
area in terms of race, ethnicity, educational attainment,
and household income.
All three participating health care systems recommend
the routine use of the PHQ9 depression questionnaire
[20] at all mental health specialty visits and all primary
care visits for treatment of depression [21]. All three sites
participated in previous research [5] demonstrating that
the response to item 9 of the PHQ9 (regarding thoughts
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of death or self-harm) predicts markedly elevated risk of
suicide attempt over the following 18 months (Fig. 1).
Eligibility
Eligibility criteria for automatic inclusion in the trial
include:
 Completion of a PHQ9 questionnaire [20] at an
outpatient mental health or general medical visit
 Age 18 years or older on the visit date
 Response of “more than half the days” or “nearly
every day” to item 9 of the PHQ9
 Use of EHR patient portal secure messaging during
the prior year
 Currently enrolled in participating health system
insurance plan (to ensure adequate ascertainment
of subsequent suicide attempts)
Exclusion criteria include:
 Recorded diagnosis of dementia or developmental
delay in the previous 2 years
 Limited English proficiency (as indicated by “need
for interpreter” recorded in the EHRs)
 Previous request to be excluded from research
invitations
 Already enrolled and randomized via a previous visit
Enrollment and randomization
Each week, EHR and insurance claim databases at each
study site are used to identify all patients who meet eligi-
bility criteria during the previous week. Immediately after
sampling, all eligible patients are randomly assigned in
equal proportions (1/3:1/3:1/3) to continue in usual care
or to be offered one of the two intervention programs. At
each site, randomization occurs automatically within the
sampling computer program, stratified by eligible PHQ9
response (“more than half the days” or “nearly every day”)
and site. A computer-generated concealed allocation table
at each site provides randomly generated assignments in
block sizes of either six or nine.
Invitation and consent
Participants assigned to the Care Management interven-
tion receive an initial invitation message from the study
care manager via the EHR-based online secure messaging
system [16, 17]. This invitation includes a brief description
of the Care Management program and abbreviated infor-
mation regarding required elements of informed consent
(study purpose, study procedures, potential risks or harms,
and right to refuse or withdraw at any time). Each partici-
pant can decline participation by replying to the invitation
Fig. 1 Trial flow chart
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message or can consent to receive intervention services by
either replying to the message or returning the attached
risk assessment questionnaire. Participants who neither
decline nor consent receive a reminder (either by online
message or telephone message) after 1 week. Participants
who neither decline nor consent after that reminder message
receive a second invitation message (with possible reminder)
4 weeks later and may receive a third invitation message
after an additional 4 weeks. Those who decline at any point
are not contacted again. Those who do not respond after
three cycles of invitation are not contacted again.
The invitation and consent process for participants
assigned to the Skills Training program parallels that for
the Care Management program: an invitation message
including abbreviated informed consent information and
up to three cycles of invitation and reminder for those
not responding. A participant can consent to receive
intervention services by replying to an invitation mes-
sage or by making an initial visit to the online interven-
tion program. Those who decline at any point are not
contacted again. Those who do not respond after three
cycles of invitation are not contacted again.
Participants assigned to continue in usual care are never
contacted by study staff. Providers are not notified regard-
ing participants’ assignment to continued usual care.
Care Management intervention
Rationale
Following the design of previous Care Management
interventions [17], including the Perfect Depression Care
program at Henry Ford Health System [11], this program
aims to reduce risk of suicide attempt by monitoring and
maintaining engagement in effective mental health
treatment.
Assessment tools
In collaboration with developers of the Columbia Suicide
Severity Rating Scale [22] (CSSRS), study investigators
developed a simplified CSSRS for self-report adminis-
tration via online secure messaging. This abbreviated
CSSRS provides a 6-point ordinal rating of current sui-
cide risk based on frequency and intensity of suicidal
thoughts, presence and specificity of suicidal plans, and
clarity of suicidal intent during the last week. For ex-
ample, a score of 0 would indicate no recent thoughts
of self-injury or suicide, a score of 3 would indicate sui-
cidal ideation with some recent thoughts about specific
means, and a score of 5 would indicate a current and
specific suicidal plan.
Follow-up algorithms
In collaboration with health system stakeholders (see
below), investigators developed rules for risk-based care
pathways specifying appropriate level of care, minimum
standards for follow-up visit intervals and timing of out-
reach messages. For example: a CSSRS score of 1 would
lead to a recommendation for follow-up within 1 month
(sooner if clinically appropriate) in either primary care or
specialty mental health care, a score of 3 would lead to a
recommendation for follow-up in specialty mental health
care within 2 weeks, and a score of 5 would lead to a rec-
ommendation for specialty mental health follow-up within
two business days (or sooner as clinically indicated).
Care manager role
At each site, one or more care managers are responsible
for:
 Initial and follow-up invitations to all participants
assigned to be offered Care Management
 Periodic outreach to assess current risk (using an
online version of the CSSRS)
 Application of follow-up algorithms, supported by
informatics tools (see below)
 Regular feedback to treating providers regarding risk
assessments and follow-up plans
 As-needed communication with participants and
providers to facilitate follow-up care
Care managers communicate with participants primar-
ily by online secure messaging through EHR patient
portals, but may communicate by telephone as needed.
Care managers are expected to consider individual pa-
tients’ clinical circumstances and providers’ treatment
plans when applying algorithms regarding outreach and
visit frequency. At all sites, care managers are Master’s-
prepared mental health clinicians.
Informatics tools
Intervention delivery is supported by existing functions
of health system EHRs:
 Online patient-provider secure messaging via the
EHR patient portal [16, 17] for invitation and out-
reach to participants
 Online administration of structured questionnaires
such as the CSSRS
 Secure provider-to-provider messaging for care
managers’ communications with primary care and
mental health specialty providers
 Population management and reporting tools to apply
follow-up algorithms and deliver algorithm-based
recommendations to care managers regarding out-
reach and follow-up
Engagement with health system stakeholders
During the pilot phase, regular meetings with clinical
leaders from all sites (representing both primary care
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and mental health specialty care) developed consensus
regarding content and workflow of the Care Management
program, including:
 Language for outreach messages
 Recommended follow-up intervals
 Criteria for referral from primary care to mental
health specialty care
 Processes for communicating with primary care and
mental health specialty providers
 Procedures for urgent assessment and referral
Training and supervision
Training of care managers across sites was conducted by
videoconference and teleconference, led by clinical investi-
gators from the Group Health site. Initial training included:
 6 h of clinical training regarding suicide risk
assessment
 2 h of general orientation to project aims and
procedures
 6 h of specific training regarding care management
aims, tools, and procedures
Ongoing teleconference supervision for all care
managers is led by clinical investigators from the Group
Health site. Supervision meetings were scheduled weekly
for 6 months and twice monthly thereafter. Consistent
with the principles of pragmatic trials [23], no detailed
monitoring of intervention fidelity (e.g., review of content
of online messaging or phone contacts) is conducted.
Skills Training intervention
Rationale
Following the content and structure of proven Dialect-
ical Behavior Therapy (DBT) treatments [8, 12], this pro-
gram aimed to reduce risk of suicide attempt through
training in specific DBT skills shown to mediate the
beneficial effects of traditional in-person DBT [12].
Specific skills content
The online program and coaching support focuses on
four specific skills:
Mindfulness – Introduction to mindfulness skills,
emphasizing nonjudgmental observation
Mindfulness of Current Emotion – Nonjudgmental
observation of sensations associated with difficult or
painful emotions
Opposite Action – Acting in opposition to urges
associated with painful or difficult emotions
Paced Breathing – Use of breathing techniques to
manage overwhelming emotions or crises
Adaptation for online delivery
The web-based interactive program includes an introduc-
tory section, personal profiles of team members (including
coaches and contributing peer experts described below),
and four skill modules (one for each DBT skill listed
above). Each module includes:
 A brief video introduction to the skill concept
 A longer teaching video describing the skill,
including in vivo practice
 Example videos of peers (see below) describing use
of the skill in daily life
 Interactive exercises for use during the online
session
 Customizable worksheets to support between-
session practice
Each participant is free to visit skills modules in any
order and use the program at any pace, returning as fre-
quently as desired. Coaches send reinforcement and out-
reach messages (see below) to encourage regular use.
Skills coach role
At each site, one or more skills coaches is responsible for:
 Initial and follow-up invitations to all participants
assigned to be offered Skills Training
 For participants visiting the online program,
messages to reinforce use of the program and
practice of specific skills
 For participants not visiting the program, periodic
outreach messages to encourage return visits
 As-needed communication with treating providers
regarding participants’ progress
Skills coaches communicate with participants primarily
by online secure messaging through EHR patient portals,
but may communicate by telephone as needed. At all
sites, skills coaches are Master’s-prepared mental health
clinicians.
Informatics tools
The online program is delivered through the DatStat
survey platform (DatStat Inc., Seattle, WA, USA). This
platform supports secure access, detailed tracking of
participant activity, and participant-level reports to guide
the timing and content of coaches’ reinforcement and re-
minder messages. Participants access the online program
via secure personalized links embedded in messages from
skills coaches.
Engagement with patient stakeholders
Peer experts (people with lived experience of suicidal idea-
tion and suicide attempts) were essential collaborators in
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the development of the Skills Training intervention and
continue to support intervention delivery [24]. Design of
outreach messages and content of the online program
were informed by anonymous online surveys and focus
group interviews with peer experts [24]. People with lived
experience contributed video descriptions of the use of
DBT skills, and continue to contribute to development of
training and support materials for skills coaches.
Training and supervision
Training of skills coaches was conducted by videoconfer-
ence and teleconference, led by clinical investigators
from the Group Health site. Initial training included:
 6 h of clinical training regarding suicide risk
assessment
 2 h of general orientation to project aims and
procedures
 6 h of specific training regarding skills coaching
aims, tools, and procedures
Ongoing teleconference supervision for all skills coa-
ches is led by clinical investigators from the Group
Health site. Supervision meetings were scheduled weekly
for 6 months and twice monthly thereafter. Consistent
with the principles of pragmatic trials [23], no detailed
monitoring of intervention fidelity (e.g., review of content
of online messaging or phone contacts) is conducted.
Outcome definitions
The primary study outcome is the time to first suicide
attempt following randomization. Fatal suicide attempts
will be identified by death certificate diagnoses of self-
inflicted injury or poisoning. All three study sites routinely
link membership files to state vital record data to ascertain
cause of death for all enrolled members. Nonfatal suicide
attempts will be identified from EHRs (for care delivered
by participating health systems) and insurance claim data
(for care received outside of participating health systems)
using three criteria:
 Any outpatient or inpatient diagnosis of definite self-
inflicted injury or poisoning
 Any outpatient or inpatient diagnosis of possible
self-inflicted injury or poisoning
 Any outpatient or inpatient diagnosis of other injury
or poisoning associated with a diagnosis of suicidal
ideation during the same encounter
For these three criteria, review of full-text medical
records documented high positive predictive value for
self-inflicted injury with suicidal intent [18, 25]. Because
this validation work was completed prior to health care
systems’ transition from the International Classification
of Diseases, version 9 (ICD-9) to ICD-10 diagnoses,
additional work will be necessary in 2016 to revalidate
outcome definitions based on ICD-10 diagnostic codes.
Given that participants may seek care for self-injury at
external facilities, ascertainment will include both insur-
ance claim and EHR data, and the sample is limited to
patients who are enrolled in a health system insurance
plan.
Analysis plan
Primary analyses will use the log-rank test to compare
risk of diagnosed suicide attempt (defined above) over
18 months following randomization. For each interven-
tion condition, risk among those assigned to the inter-
vention will be compared to risk among those assigned
to usual care – regardless of level of participation in ei-
ther intervention. Individuals will be censored at time of
health system disenrollment, death from cause other
than suicide, or administratively, at 18 months following
randomization. We evaluate the effect of each of the in-
terventions compared to usual care using a log-rank test
stratified by site and initial response to PHQ9 item 9 (2
versus 3). Sensitivity analyses will use weighted log-rank
tests to account for a possible association between pre-
randomization characteristics (ascertained from EHRs)
and censoring. In censoring weights, we will include
sex, age group (18–29, 30–64, and 65 or more), race/
ethnicity (Black American, Asian American, Hispanic,
other), and visit type at which the initial PHQ9 ques-
tionnaire was completed (primary care versus mental
health specialty).
Sample size
Original sample size estimates were based on previous
research [5] suggesting an approximately 4 % risk of
suicide attempt over 18 months among those meeting
study eligibility criteria. Consultation with health sys-
tem stakeholders indicated that implementation of a
systematic outreach program was unlikely unless a pro-
gram could be expected to reduce that risk to 3 % (rela-
tive risk reduction of 25 %). We used PASS software
[26] to estimate the sample size required for a log-rank
test [27] with 90 % power to compare the survival
curves assuming a 3.8 % risk over 18 months in the
comparison group and a 25 % risk reduction in the
intervention group. We assumed 2 % disenrollment
rate each month, resulting in approximately 25 % cen-
sorship over the 18 months of follow-up. The primary
comparison for this trial is each of the interventions
compared to usual care; we use a Bonferroni correction
to account for the two tests in our primary analysis. As-
suming a two-sided log-rank test, with a type-1 error
rate of 0.025 and 90 %, we plan on enrolling 6500 pa-
tients per arm (total n = 19,500).
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Enrollment progress
The trial was funded through the NIH Health Care
Systems Collaboratory as one of the initial Pragmatic Clin-
ical Trials Demonstration Projects [28]. Following a pilot
phase to validate outcome definitions and to demonstrate
the feasibility and acceptability of the intervention pro-
grams, participant enrollment and randomization began
at the Group Health site in March 2015, expanding to
three sites in July 2015. Approximately 4000 participants
have been enrolled and randomized as of 1 July 2016. Ap-
proximately 100 participants are enrolled and randomized
each week, and that rate is expected to increase to ap-
proximately 150 in the fall of 2016.
Ethical and regulatory approval
Study design and procedures were reviewed and ap-
proved by Institutional Review Boards at all three health
system. That review process addressed several issues
common to pragmatic trials of prevention interventions.
Waiver of informed consent
Limiting a randomized trial of outreach to those who ac-
tively consent to receive outreach would yield a result of
questionable validity and generalizability. Consequently, a
modified Zelen design [13–15], randomizing all eligible pa-
tients without first obtaining consent, is necessary for valid
test of the study question. This design, however, requires a
waiver of the usual requirement for informed consent prior
to enrollment or randomization. While it is not practicable
to obtain informed consent prior to randomization, it is
practicable to provide appropriate information to partici-
pants at the time intervention services are offered. As de-
scribed above, invitation messages to participants assigned
to either intervention include a brief description of the study
purpose, study procedures, potential risks, and the right to
decline participation. This design, therefore, includes a wai-
ver of consent for enrollment/randomization and a modified
consent procedure for receipt of intervention services.
Defining minimal risk
Current regulations regarding protection of human re-
search participants allow waiver of consent for research in-
volving no more than minimal risk. Our proposal to waive
the requirement for informed consent in patients who are
at risk of suicide attempt led to extensive discussions with
health system Institutional Review Boards, leadership of
the NIH Healthcare Systems Research Collaboratory, and
the federal Office for Human Research Protections [29].
Those discussions helped to clarify four issues:
 Research risk versus preexisting risk – Given that the
trial enrolls patients who are at risk of suicide
attempt, we encountered concern that study
procedures could not be classified as having minimal
risk. To address this concern, we relied on regulatory
guidance distinguishing between preexisting risk due
to a research participant’s health state (i.e., increased
risk of suicide attempt) and incremental risk created
by study procedures. This distinction led to the
appreciation of this trial as evaluating minimal-risk
interventions in a high-risk population
 Risk of assignment to continued usual care – We
also encountered concern regarding the ethical
acceptability of randomly assigning patients who are
at risk of suicide attempt to a usual care control
condition. We clarified that a participant assigned to
usual care will, by definition, receive the same
treatment that she or he would have received if the
study were not occurring
 Risk of assignment to offer of intervention programs
– We also encountered concern that assignment to
either intervention group might increase risk. Both
intervention programs are based on effective
interventions and are intended to reduce risk of
suicide attempt. Participants are free to receive any
other services that are normally available.
Nevertheless, it is possible that some participants will
experience negative effects from either program. We
addressed this concern by clarifying that participants
are assigned to the offer of an intervention, with no
obligation to participate. Invitation messages clearly
identify intervention programs as research activities,
make no promise of benefit, and advise that
participation is completely voluntary
 Intrusiveness or invasion of privacy – Different
stakeholders expressed concern regarding both
inappropriate intrusiveness of repeated outreach and
inadequate vigor of outreach given the known increased
risk of suicide attempt. In consultation with peer
experts, we designed the outreach strategy described
above, including up to three cycles of invitation, as a
reasonable compromise between these two concerns.
At all participating health systems, notices regarding
privacy practices specifically advise members regarding
the use of health records for research. Members who
have previously requested exclusion from research con-
tact are excluded from the study sample.
Monitoring for adverse events
In most clinical trials of mental health treatments, a suicide
attempt would be considered a serious adverse event, sub-
ject to immediate reporting and review to determine the
“relatedness” of an individual suicide attempt to study par-
ticipation. This traditional approach was clearly not appro-
priate for a large-scale trial of population-based prevention
programs [30]. First, record data regarding suicide attempts
may not be available for 3 months or more following an
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event. Second, several hundred suicide attempts are ex-
pected to occur among study participants, and review of in-
dividual events could not determine causal relationship to
study participation. While it is possible that either interven-
tion could paradoxically increase risk of suicide attempt,
that could only be determined by comparison to suicide at-
tempt rates in usual care (see below).
Interim analyses of benefit or harm
We do not plan any interim analyses to evaluate benefit
of the intervention programs. First, early detection of a
benefit of either intervention is extremely unlikely. We
project that randomization will be complete before
complete outcome data are available for half of the
participants. Second, early termination of randomization
or intervention delivery would not offer any additional
protection to current or future study participants. Pre-
mature termination would instead return all current and
potential participants to care as usual.
We do, however, plan interim analyses testing for
evidence of significant harm (increased risk of suicide
attempt) in either intervention group compared to usual
care. Clear evidence that either intervention resulted in
significantly increased risk of suicide attempt would cer-
tainly warrant suspending assignment of patients to that
program or suspending delivery of that program to partici-
pants already assigned. Interim analyses comparing risk of
suicide attempt in each intervention group to that in usual
care will be conducted three times per year, beginning
12 months after start of enrollment. Interim analyses will
be reported to the National Institute of Mental Health
Data and Safety Monitoring Board by the study statistician,
but all other study staff will be blinded to these results.
Data and resource sharing
A deidentified version of the analytic dataset will be
made available at the time of the initial publication of
primary study findings. Consistent with policies of the
NIH Collaboratory, all resources (intervention materials,
specifications, computer code, etc.) will be shared at or
before the publication of study results.
Discussion
This suicide prevention outreach trial addresses a prac-
tical question that is relevant to practicing clinicians or
Table 1 PRECIS domains defining pragmatic trials
PRECIS criteria for pragmatic trials Design of suicide prevention outreach trial
Participants All eligible participants enrolled, regardless of risk,
responsiveness, comorbidities or past compliance
Adult health plan members reporting frequent suicidal
ideation on routine depression questionnaires are
automatically enrolled
Intervention condition Interventions are highly flexible, offering providers leeway
in formulation and application
Both interventions allow personalization to patients’ needs
and preferences. Varying levels of participation are expected
Intervention practitioners Interventions are applied by the full range of practitioners
in the full range of settings with only ordinary attention to
dose and side effects
Intervention clinicians will be recruited from existing
local workforces. Each site will be responsible for
selection and supervision of clinicians (using standard
quality control tools)
Comparison condition “Usual practice” (or the best alternative), offering
practitioners considerable leeway in application
Each prevention program will be compared to usual care
Comparison practitioners The control intervention is applied by the full range of
clinicians in the full range of settings, with only ordinary
attention to training, experience, and performance
Usual care will be provided by real-world providers
(mental health and general medical clinicians) under
usual practice conditions – with no additional training
or supervision
Follow-up assessments There are no research assessments; administrative
databases are searched for outcomes
All outcome data are collected from EHR, insurance claim
data, and death certificate data
Outcome definition The primary outcome is objectively measured, meaningful
to study participants, and does not depend on central
adjudication
Primary and secondary outcomes are defined by specific
ICD-9/ICD-10 diagnosis codes – no clinical assessment is
required
Intervention compliance There are no special strategies to improve compliance, and
compliance is unobtrusively measured
Patients assigned to interventions are free to participate (or
not participate) at any level. Participation or compliance is
assessed passively using EHRs and online intervention
databases
Practitioner adherence There are no special strategies to maintain practitioner
adherence, and adherence is unobtrusively measured
Care managers and skills coaches work independently at
each site, but receive initial training and regular supervision
from study investigators
Primary comparison The analysis includes all patients regardless of compliance,
eligibility, or others
All outcomes will be analyzed according to initial
assignment – regardless of intervention participation or
compliance
EHR electronic health record, ICD International Classification of Diseases
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health system leaders: Will population-based outreach
programs reduce risk of suicide attempt among patients
identified as being at risk by routinely administered
depression questionnaires? This focus on a practical or
pragmatic question has several implications for trial
design. Table 1 describes how specific aspects of this
trial conform to the characteristics of pragmatic trials
described by Thorpe [31]. Central pragmatic trial features
include:
 Population-based enrollment – If we hope to inform
policy or implementation decisions by health system
leaders, then it is necessary to evaluate program
effectiveness in the full population of those to whom
the program would eventually be offered
 Allowing variable participation or compliance –
Restricting enrollment to those willing to participate
in outreach or prevention programs would not allow
a valid assessment of program effectiveness. Low
participation or high rates of dropout should be
considered essential indicators of effectiveness rather
than threats to internal validity
 Analysis by intent-to-treat – A valid evaluation of
prevention program effectiveness must examine risk
among all those offered the prevention service, rather
than those who accept or participate. Any “as treated”
or “completers” analysis (limited to those who
participate in prevention services) would certainly
be biased
Our trial differs from a purely pragmatic design in one
aspect: the training and supervision of clinical staff deliv-
ering the prevention interventions. All care managers
and skills coaches complete approximately 14 h of initial
training followed by weekly or bi-weekly supervision
teleconferences. This training and supervision was ne-
cessary because both of these clinical roles required
implementation of new clinical work processes and the
use of new informatics tools. If either program is proven
effective, we would recommend that any subsequent im-
plementation include a similar level of training as well as
a period of regular supervision.
Assessing the effectiveness of any population-based pre-
vention program requires a clinical trial following the core
principles of pragmatic trials: population-based enroll-
ment, accepting variable treatment participation, assessing
outcomes using health record data, and analyses based on
intent-to-treat. We describe the design and implementa-
tion of such a trial, now underway in three large integrated
health systems.
Trial status
Enrollment is ongoing and is expected to be complete in
early 2018.
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